Zsolt Sebestyén

2.6k total citations
49 papers, 1.7k citations indexed

About

Zsolt Sebestyén is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Zsolt Sebestyén has authored 49 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 34 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Zsolt Sebestyén's work include CAR-T cell therapy research (33 papers), Immune Cell Function and Interaction (27 papers) and T-cell and B-cell Immunology (19 papers). Zsolt Sebestyén is often cited by papers focused on CAR-T cell therapy research (33 papers), Immune Cell Function and Interaction (27 papers) and T-cell and B-cell Immunology (19 papers). Zsolt Sebestyén collaborates with scholars based in Netherlands, United States and Hungary. Zsolt Sebestyén's co-authors include Jürgen Kuball, János Szöllõsi, Péter Nagy, Reno Debets, Sabine Heijhuurs, Wouter Scheper, Trudy Straetemans, Anton C. Martens, Ralph A. Willemsen and John W. Park and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature reviews. Cancer.

In The Last Decade

Zsolt Sebestyén

46 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zsolt Sebestyén Netherlands 22 1.0k 988 468 206 203 49 1.7k
Ignacio Moraga United States 22 1.3k 1.3× 957 1.0× 680 1.5× 116 0.6× 360 1.8× 34 2.2k
Nienke van Rooij Netherlands 12 1.3k 1.3× 1.2k 1.2× 611 1.3× 115 0.6× 122 0.6× 22 1.9k
Ekaterina Doubrovina United States 21 832 0.8× 972 1.0× 373 0.8× 344 1.7× 153 0.8× 59 1.7k
Michael S. Kuhns United States 19 2.4k 2.4× 1.4k 1.4× 515 1.1× 218 1.1× 216 1.1× 27 3.2k
Angela M. Krackhardt Germany 23 965 0.9× 965 1.0× 769 1.6× 211 1.0× 252 1.2× 58 1.8k
Michele Weber United Kingdom 15 1.3k 1.3× 524 0.5× 539 1.2× 131 0.6× 247 1.2× 21 2.2k
Arnob Banerjee United States 22 2.0k 1.9× 1.2k 1.2× 959 2.0× 122 0.6× 225 1.1× 66 3.1k
Blythe Sather United States 19 1.1k 1.1× 733 0.7× 671 1.4× 442 2.1× 65 0.3× 29 2.0k
Amer Najjar United States 18 413 0.4× 1000 1.0× 517 1.1× 276 1.3× 145 0.7× 29 1.6k
Kirsten Tangemann United States 13 867 0.8× 628 0.6× 739 1.6× 103 0.5× 203 1.0× 14 2.0k

Countries citing papers authored by Zsolt Sebestyén

Since Specialization
Citations

This map shows the geographic impact of Zsolt Sebestyén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zsolt Sebestyén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zsolt Sebestyén more than expected).

Fields of papers citing papers by Zsolt Sebestyén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zsolt Sebestyén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zsolt Sebestyén. The network helps show where Zsolt Sebestyén may publish in the future.

Co-authorship network of co-authors of Zsolt Sebestyén

This figure shows the co-authorship network connecting the top 25 collaborators of Zsolt Sebestyén. A scholar is included among the top collaborators of Zsolt Sebestyén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zsolt Sebestyén. Zsolt Sebestyén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brázda, Péter, Esmée J. van Vliet, Zsolt Sebestyén, et al.. (2025). Autologous profiling reveals inter-patient heterogeneity in Vδ2 + γδTIL responses to glioblastoma driven by extracellular matrix-BTN3A axis. Journal for ImmunoTherapy of Cancer. 13(12). e013018–e013018.
2.
Meringa, Angelo D., Ronald W. Stam, Rishi S. Kotecha, et al.. (2024). Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML. Journal for ImmunoTherapy of Cancer. 12(4). e008174–e008174. 3 indexed citations
3.
Alieva, María, Sam de Blank, Amber L. Zeeman, et al.. (2024). BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor response. Nature Protocols. 19(7). 2052–2084. 9 indexed citations
4.
Mamedov, Murad R., Jacob W. Freimer, Avinash Sahu, et al.. (2023). CRISPR screens decode cancer cell pathways that trigger γδ T cell detection. Nature. 621(7977). 188–195. 49 indexed citations
5.
Meringa, Angelo D., Arjen H.G. Cleven, Trudy Straetemans, et al.. (2023). Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies. Frontiers in Immunology. 14. 1159337–1159337. 3 indexed citations
6.
Slomp, Anne, Anne W. J. Martens, Shuang Li, et al.. (2023). Serpin B9 controls tumor cell killing by CAR T cells. Journal for ImmunoTherapy of Cancer. 11(3). e006364–e006364. 16 indexed citations
7.
Meringa, Angelo D., Sabine Heijhuurs, Inez Johanna, et al.. (2021). Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds. Journal for ImmunoTherapy of Cancer. 9(11). e003850–e003850. 32 indexed citations
8.
Scheper, Wouter, Tineke Aarts‐Riemens, Dennis X. Beringer, et al.. (2021). Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells. Molecular Therapy — Methods & Clinical Development. 22. 388–400. 5 indexed citations
9.
Straetemans, Trudy, K.M.B. Jansen, Remco van Doorn, et al.. (2020). TEG001 insert integrity from vector producer cells until medicinal product. Cytotherapy. 22(5). S137–S137. 2 indexed citations
10.
Minnema, Monique C., Zsolt Sebestyén, Trudy Straetemans, et al.. (2018). Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model. OncoImmunology. 7(6). e1434465–e1434465. 54 indexed citations
11.
Straetemans, Trudy, Sabine Heijhuurs, Samantha Hol, et al.. (2015). Untouched GMP-Ready Purified Engineered Immune Cells to Treat Cancer. Clinical Cancer Research. 21(17). 3957–3968. 22 indexed citations
12.
Scheper, Wouter, et al.. (2014). Cancer Immunotherapy Using γδT Cells: Dealing with Diversity. Frontiers in Immunology. 5. 601–601. 35 indexed citations
13.
Govers, Coen, Zsolt Sebestyén, Jason Roszik, et al.. (2014). TCRs Genetically Linked to CD28 and CD3ε Do Not Mispair with Endogenous TCR Chains and Mediate Enhanced T Cell Persistence and Anti-Melanoma Activity. The Journal of Immunology. 193(10). 5315–5326. 38 indexed citations
14.
Drent, Esther, Richard W.J. Groen, Willy A. Noort, et al.. (2014). CD38 Chimeric Antigen Receptor Engineered T Cells As Therapeutic Tools for Multiple Myeloma. Blood. 124(21). 4759–4759. 6 indexed citations
15.
Scheper, Wouter, et al.. (2013). Hunting for clinical translation with innate-like immune cells and their receptors. Leukemia. 28(6). 1181–1190. 37 indexed citations
16.
Govers, Coen, Zsolt Sebestyén, Miriam Coccoris, Ralph A. Willemsen, & Reno Debets. (2010). T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing. Trends in Molecular Medicine. 16(2). 77–87. 75 indexed citations
17.
18.
Willemsen, Ralph A., Zsolt Sebestyén, C. P. M. Ronteltap, et al.. (2006). CD8α Coreceptor to Improve TCR Gene Transfer to Treat Melanoma: Down-Regulation of Tumor-Specific Production of IL-4, IL-5, and IL-10. The Journal of Immunology. 177(2). 991–998. 21 indexed citations
19.
Mocanu, Maria‐Magdalena, Péter Nagy, Zsolt Sebestyén, et al.. (2005). Associations of ErbB2, β1-integrin and lipid rafts on Herceptin (Trastuzumab) resistant and sensitive tumor cell lines. Cancer Letters. 227(2). 201–212. 36 indexed citations
20.
Nagy, Péter, György Vereb, Zsolt Sebestyén, et al.. (2002). Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2. Journal of Cell Science. 115(22). 4251–4262. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ignacio Moraga Breakdown of academic impact, for papers by Nienke van Rooij Breakdown of academic impact, for papers by Ekaterina Doubrovina Breakdown of academic impact, for papers by Michael S. Kuhns Breakdown of academic impact, for papers by Angela M. Krackhardt Breakdown of academic impact, for papers by Michele Weber Breakdown of academic impact, for papers by Arnob Banerjee Breakdown of academic impact, for papers by Blythe Sather Breakdown of academic impact, for papers by Amer Najjar Breakdown of academic impact, for papers by Kirsten Tangemann
Rankless by CCL
2026